Nathan Scott Fine
Ex-Officio Vice ChairmanMr. Nathan Scott Fine serves as Ex-officio Vice Chairman at Rafael Holdings, Inc. since July 14, 2025. He was Chief Executive Officer of Cyclo Therapeutics, Inc. (formerly known as CTD Holdings, Inc.) since September 14, 2015 until July 31, 2025. Mr. Fine served as the Chairman of Cyclo Therapeutics, Inc. since September 14, 2015 until 2020. Mr. Fine has been involved in investment banking, working on a multitude of debt and equity financings, buy and sell side M&A, strategic advisory work and corporate restructurings. Mr. Fine has led global transactions in healthcare, including medical devices, generic pharmaceuticals and genetics. He was Principal at Scarsdale Equities from 2004 to 2014. Mr. Fine founded Fine Equities, Inc. and served as its President and investment banker. He has been involved in corporate finance for years. He focused his efforts and worked or initiated several transactions in the healthcare and consumer products area, including: In healthcare he advised Research Medical, a specialty medical device manufacturer. He was the lead investment banker on the Initial Public Offering for Med-Design Corporation. Mr. Fine was the Lead Investment Banker for DermaSciencs, Inc. He advised on several funding transactions for Interleukin Genetics (AMEX ILI). He served as a Special Internal Advisor to The Tempo Group of Jakarta, Indonesia. He advised and was the lead Investment banker on the Initial Public Offering of Green Mountain Coffee Roasters, Inc. and Roust Corporation (formerly Central European Distribution Corp.). He served as the Chairman of Global Virus Network since January 8, 2015. He served as the Executive Chairman of Cyclo Therapeutics, Inc. since January 16, 2015 until September 2015. He served as Vice Chairman at Pacific Drilling S.A. since June 2, 2017 and served as its Director since December 6, 2016. He served as the Chairman of Cyclo Therapeutics, Inc. from October 1, 2014 to January 16, 2015. He served as Vice Chairman and Lead Director of Cyclo Therapeutics, Inc. from May 16, 2014 to October 1, 2014. He served as Vice Chairman of at Roust Corporation (formerly Central European Distribution Corp.) since October 23, 2012 until July 18, 2014. He served as a Lead Director of Forward Industries, Inc. He has been a Director of Global Virus Network since January 16, 2013. He has been an Independent Director of Kenon Holdings Ltd. since 2014. He is a Director at Cyclo Therapeutics, Inc. since February 2014. He was a Director at Forward Industries, Inc. from December 2014 to December 2017. Mr. Fine also served as Sole Director of Better Place Inc. from 2013 until 2015. In his role there, Mr. Fine successfully managed the global wind down in a timely and efficient manner which was approved by both the Delaware and Israeli Courts. He was on the Board of Trustees for the IWM American Air Museum in Britain. Mr. Fine served as a Director of CEDC for over a decade. He served as a Director of at Roust Corporation (formerly Central European Distribution Corp.) since 1996 until July 18, 2014 and served as its Lead Director since July 9, 2012 until July 18, 2014. Mr. Fine has been a guest lecturer at Ohio State University’s Moritz School of Law. He served as a Director of LifeScience PLUS, Inc. Mr. Fine sits on the Deans Advisory Board for The University of Connecticut’s Neag School of Education at Storrs, Connecticut. Mr. Fine attended New Hampshire College where he studied Business Administration.
Positions
- Company NameRafael Holdings, Inc.Stock CodeRFLPositionEx-Officio Vice ChairmanColleagues
- Company NameKenon Holdings Ltd.Stock CodeKENPositionIndependent Director
